EYPT:NASDAQ
EyePoint Inc
၃.၄၀ US$
arrow_downward
-၁.၇၃%(-၀.၀၆၀) 1D
၃.၄၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၃ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၃ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
News stories
From web sources and news partners
Business Wire
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
Seeking Alpha
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
3 things to look out for on Monday (SP500:)
GuruFocus
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees၂၁၄
Founded၂၀၀၀
HeadquartersWatertown, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteeyepoint.bio